These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 33284384)

  • 21. Seretide for obstructive lung disease.
    Chapman KR
    Expert Opin Pharmacother; 2002 Mar; 3(3):341-50. PubMed ID: 11866683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison table: Inhaled corticosteroids for treatment of COPD.
    Med Lett Drugs Ther; 2020 Sep; 62(1606):e148-e149. PubMed ID: 32960875
    [No Abstract]   [Full Text] [Related]  

  • 23. Fluticasone Propionate/Salmeterol MDPI (AirDuo RespiClick
    Paik J; Scott LJ; Pleasants RA
    Clin Drug Investig; 2018 May; 38(5):463-473. PubMed ID: 29582249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of the efficacy and safety of fluticasone propionate and salmeterol delivered as a combination dry powder via a capsule-based inhaler and a multi-dose inhaler in patients with asthma.
    Chan R; Sousa AR; Mallett S; Hynds P; Homayoun-Valiani F; Tabberer M; Mehta R
    Pulm Pharmacol Ther; 2016 Dec; 41():19-24. PubMed ID: 27599598
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative Analysis of Persistence to Treatment among Patients with Asthma or COPD Receiving AirFluSal Forspiro or Seretide Diskus Salmeterol/Fluticasone Propionate Combination Therapy.
    Bender BG; Hernandez Vecino RA; McGrath K; Jones S
    J Allergy Clin Immunol Pract; 2016; 4(5):884-9. PubMed ID: 27587319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting beta2-agonists.
    Murray J; Rosenthal R; Somerville L; Blake K; House K; Baitinger L; VanderMeer A; Dorinsky P
    Ann Allergy Asthma Immunol; 2004 Oct; 93(4):351-9. PubMed ID: 15521371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma.
    Galant SP; van Bavel J; Finn A; Gross G; Pleskow W; Brown A; Hamedani AG; Harding SM
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):273-80. PubMed ID: 10094218
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Dose-Response Study Examining the Use of Methacholine Challenge to Demonstrate Local Therapeutic Equivalence of the Salmeterol Component of Generic Inhaled Fluticasone Propionate/Salmeterol Combination Products.
    Allan R; Haughie S; Ahrens R; Singh S; Ward J
    J Aerosol Med Pulm Drug Deliv; 2019 Dec; 32(6):352-363. PubMed ID: 31259673
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparative pulmonary function and pharmacokinetics of fluticasone propionate and salmeterol xinafoate delivered by two dry powder inhalers to patients with asthma.
    Harrison LI; Novak CC; Needham MJ; Ratner P
    J Aerosol Med Pulm Drug Deliv; 2011 Oct; 24(5):245-52. PubMed ID: 21671752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma.
    Markham A; Jarvis B
    Drugs; 2000 Nov; 60(5):1207-33. PubMed ID: 11129128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advair: combination treatment with fluticasone propionate/salmeterol in the treatment of asthma.
    Nelson HS
    J Allergy Clin Immunol; 2001 Feb; 107(2):398-416. PubMed ID: 11174215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhaled fluticasone propionate delivered by means of two different multidose powder inhalers is effective and safe in a large pediatric population with persistent asthma.
    Peden DB; Berger WE; Noonan MJ; Thomas MR; Hendricks VL; Hamedani AG; Mahajan P; House KW
    J Allergy Clin Immunol; 1998 Jul; 102(1):32-8. PubMed ID: 9679845
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: a randomized, double-blind, placebo-controlled trial.
    Kavuru M; Melamed J; Gross G; Laforce C; House K; Prillaman B; Baitinger L; Woodring A; Shah T
    J Allergy Clin Immunol; 2000 Jun; 105(6 Pt 1):1108-16. PubMed ID: 10856143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukast.
    Nelson HS; Busse WW; Kerwin E; Church N; Emmett A; Rickard K; Knobil K
    J Allergy Clin Immunol; 2000 Dec; 106(6):1088-95. PubMed ID: 11112891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expanded table: Some inhaled drugs for treatment of asthma.
    Med Lett Drugs Ther; 2020 Dec; 62(1613):e200-e203. PubMed ID: 33446623
    [No Abstract]   [Full Text] [Related]  

  • 36. Inhaled salmeterol/fluticasone propionate combination in chronic obstructive pulmonary disease.
    Lyseng-Williamson KA; Keating GM
    Am J Respir Med; 2002; 1(4):273-82; discussion 283-4. PubMed ID: 14720047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Systematic review and Meta-analysis on efficacy and safety of Liujunzi Decoction combined with Western medicine for stable chronic obstructive pulmonary disease].
    Yi-Ling F; Qing M; Xing L; Chang-Zheng F; Mao-Rong F; Qing C; Ning W; Qiu-Xiao MA; Ya-Ni H
    Zhongguo Zhong Yao Za Zhi; 2020 Nov; 45(22):5331-5343. PubMed ID: 33350192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparing the efficacy and safety of salmeterol/fluticasone pMDI versus its mono-components, other LABA/ICS pMDIs and salmeterol/fluticasone Diskus in patients with asthma.
    Mehta N; Aggarwal B; Gogtay J; Abdool-Gaffar S
    Expert Opin Drug Deliv; 2015 Jun; 12(6):963-75. PubMed ID: 25429610
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of Salmeterol and Fluticasone Propionate Delivered in Combination via Easyhaler and Diskus Dry Powder Inhalers in Healthy Subjects.
    Kirjavainen M; Mattila L; Vahteristo M; Korhonen J; Lähelmä S
    J Aerosol Med Pulm Drug Deliv; 2018 Oct; 31(5):290-297. PubMed ID: 29493402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fluticasone propionate/salmeterol for the treatment of chronic-obstructive pulmonary disease.
    Dransfield MT; Bailey WC
    Expert Opin Pharmacother; 2004 Aug; 5(8):1815-26. PubMed ID: 15264996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.